Toolkit/optogenetic MAPK inhibitor

optogenetic MAPK inhibitor

Construct Pattern·Research·Since 2017

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The optogenetic MAPK inhibitor is a reported construct design that uses light to inhibit MAPK signaling. In a 2017 Nature Communications report, this design was used to reveal resonance between transcription-regulating circuitry and temporally encoded inputs.

Usefulness & Problems

Why this is useful

This tool is useful for perturbing MAPK signaling with light as the input modality while probing how transcriptional circuitry responds to temporal patterns. The available evidence specifically supports its use for studying resonance between transcription-regulating circuitry and temporally encoded inputs.

Problem solved

It addresses the problem of controlling MAPK inhibition with an optogenetic input in order to interrogate temporally encoded signaling effects on transcription. The evidence does not provide further detail on the exact MAPK node, molecular architecture, or experimental context.

Problem links

Need precise spatiotemporal control with light input

Derived

The optogenetic MAPK inhibitor is a reported construct design that uses light to inhibit MAPK signaling. In a 2017 Nature Communications report, this design was used to reveal resonance between transcription-regulating circuitry and temporally encoded inputs.

Need tighter control over gene expression timing or amplitude

Derived

The optogenetic MAPK inhibitor is a reported construct design that uses light to inhibit MAPK signaling. In a 2017 Nature Communications report, this design was used to reveal resonance between transcription-regulating circuitry and temporally encoded inputs.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Target processes

transcription

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: regulator

Implementation is known only at the level that this is an optogenetic construct pattern using light to control MAPK inhibition. The evidence does not state construct composition, cofactors, delivery method, expression system, or assay configuration.

The supplied evidence does not specify the inhibitor components, light-responsive domain, wavelength, kinetics, dynamic range, or organismal system. Independent replication, comparative benchmarking, and breadth of validation are not established from the provided material.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1biological findingsupports2017Source 1needs review

The reported optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally encoded inputs.

Claim 2biological findingsupports2017Source 1needs review

The reported optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally encoded inputs.

Claim 3biological findingsupports2017Source 1needs review

The reported optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally encoded inputs.

Claim 4biological findingsupports2017Source 1needs review

The reported optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally encoded inputs.

Claim 5biological findingsupports2017Source 1needs review

The reported optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally encoded inputs.

Claim 6biological findingsupports2017Source 1needs review

The reported optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally encoded inputs.

Claim 7biological findingsupports2017Source 1needs review

The reported optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally encoded inputs.

Claim 8design reportsupports2017Source 1needs review

The paper reports a simple optogenetic MAPK inhibitor design.

Claim 9design reportsupports2017Source 1needs review

The paper reports a simple optogenetic MAPK inhibitor design.

Claim 10design reportsupports2017Source 1needs review

The paper reports a simple optogenetic MAPK inhibitor design.

Claim 11design reportsupports2017Source 1needs review

The paper reports a simple optogenetic MAPK inhibitor design.

Claim 12design reportsupports2017Source 1needs review

The paper reports a simple optogenetic MAPK inhibitor design.

Claim 13design reportsupports2017Source 1needs review

The paper reports a simple optogenetic MAPK inhibitor design.

Claim 14design reportsupports2017Source 1needs review

The paper reports a simple optogenetic MAPK inhibitor design.

Approval Evidence

1 source2 linked approval claimsfirst-pass slug optogenetic-mapk-inhibitor
A simple optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally-encoded inputs

Source:

biological findingsupports

The reported optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally encoded inputs.

Source:

design reportsupports

The paper reports a simple optogenetic MAPK inhibitor design.

Source:

Comparisons

Source-backed strengths

The reported strength is conceptual simplicity, as the source describes it as a simple optogenetic MAPK inhibitor design. It was sufficiently functional in the reported study to reveal resonance between transcription-regulating circuitry and temporally encoded inputs.

Compared with 4pLRE-cPAOX1

optogenetic MAPK inhibitor and 4pLRE-cPAOX1 address a similar problem space because they share transcription.

Shared frame: same top-level item type; shared target processes: transcription; same primary input modality: light

optogenetic MAPK inhibitor and blue-light-activated DNA template ON switch address a similar problem space because they share transcription.

Shared frame: same top-level item type; shared target processes: transcription; same primary input modality: light

optogenetic MAPK inhibitor and VP16-EL222 light-responsive transcription factor address a similar problem space because they share transcription.

Shared frame: same top-level item type; shared target processes: transcription; same primary input modality: light

Ranked Citations

  1. 1.
    StructuralSource 1Nature Communications2017Claim 1Claim 2Claim 3

    Extracted from this source document.